Allworth Financial’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Buy
870
+22
+3% +$6.73K ﹤0.01% 1245
2026
Q1
$213K Sell
848
-183
-18% -$45.5K ﹤0.01% 1367
2025
Q4
$284K Buy
1,031
+261
+34% +$71.4K ﹤0.01% 1172
2025
Q3
$202K Buy
770
+313
+68% +$76.1K ﹤0.01% 1298
2025
Q2
$100K Buy
457
+2
+0.4% +$428 ﹤0.01% 1555
2025
Q1
$95.8K Buy
455
+317
+230% +$87.4K ﹤0.01% 1251
2024
Q4
$48K Buy
138
+29
+27% +$9.13K ﹤0.01% 1591
2024
Q3
$32.7K Sell
109
-242
-69% -$74.1K ﹤0.01% 1598
2024
Q2
$112K Buy
351
+1
+0.3% +$353 ﹤0.01% 1036
2024
Q1
$139K Buy
350
+16
+5% +$5.92K ﹤0.01% 904
2023
Q4
$118K Sell
334
-27
-7% -$9.55K ﹤0.01% 889
2023
Q3
$135K Sell
361
-15
-4% -$5.8K ﹤0.01% 778
2023
Q2
$144K Sell
376
-54
-13% -$19.3K ﹤0.01% 779
2023
Q1
$149K Buy
430
+35
+9% +$10.2K ﹤0.01% 721
2022
Q4
$93K Buy
395
+144
+57% +$34.1K ﹤0.01% 838
2022
Q3
$62K Buy
251
+128
+104% +$39K ﹤0.01% 890
2022
Q2
$37K Buy
123
+51
+71% +$16.6K ﹤0.01% 1005
2022
Q1
$30K Buy
72
+42
+140% +$16.4K ﹤0.01% 1081
2021
Q4
$14K Buy
30
+2
+7% +$861 ﹤0.01% 1279
2021
Q3
$12K Buy
+28
New +$11.8K ﹤0.01% 1246

Other funds holding WST

Allworth Financial's WST Position: Q2 2026 in Review

Allworth Financial increased its West Pharmaceutical (WST) stake by 2.6% in Q2 2026, buying an estimated $6.73K and bringing the position to 870 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #1245.

Allworth Financial first reported a position in WST in Q3 2021 and has held it in 20 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Allworth Financial held 870 shares of West Pharmaceutical worth $312K as of Q2 2026.
  • Allworth Financial bought 22 West Pharmaceutical shares in Q2 2026, an estimated $6.73K.
  • West Pharmaceutical made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #1245 holding.
  • Allworth Financial first reported a position in West Pharmaceutical in Q3 2021 and has held it in 20 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.